Doxycycline Hyclate en es it fr

Doxycycline Hyclate Brand names, Doxycycline Hyclate Analogs

Doxycycline Hyclate Brand Names Mixture

  • No information avaliable

Doxycycline Hyclate Chemical_Formula


Doxycycline Hyclate RX_link

Doxycycline Hyclate fda sheet

Doxycycline_Hyclate FDA

Doxycycline Hyclate msds (material safety sheet)

Doxycycline_Hyclate MSDS

Doxycycline Hyclate Synthesis Reference

C. R. Stephens et al.; J. Am. Chem. Soc. 80; 5324 (1958)

Doxycycline Hyclate Molecular Weight

444.435 g/mol

Doxycycline Hyclate Melting Point

201 oC

Doxycycline Hyclate H2O Solubility

630 mg/L

Doxycycline Hyclate State


Doxycycline Hyclate LogP


Doxycycline Hyclate Dosage Forms

Tablet; Capsule; Gel; Liquid; Powder; Powder for solution

Doxycycline Hyclate Indication

For the treatment of the following infections:Rocky mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox, and tick fevers caused by Rickettsiae, Chancroid caused by Haemophilus ducreyi, Uncomplicated gonorrhea caused by Neisseria gonorrhoeae, Respiratory tract infections caused by Mycoplasma pneumoniae or Streptococcus pneumoniae. Lymphogranuloma ve

Doxycycline Hyclate Pharmacology

Doxycycline, a long-acting tetracycline derived from oxytetracycline, is used to inhibit bacterial protein synthesis and treat non-gonococcal urethritis and cervicitis, exacerbations of bronchitis in patients with COPD, and adult periodontitis.

Doxycycline Hyclate Absorption

completely absorbed after oral administration

Doxycycline Hyclate side effects and Toxicity

anorexia, nausea, diarrhoea, glossitis, dysphagia, enterocolitis and inflammatory lesions (with monilial overgrowth) in the anogenital region. skin reactions such as maculopapular and erythematous rashes, exfoliative dermatitis, photosensitivity, hypersensitivity reactions such as urticaria, angioneurotic oedema, anaphylaxis, anaphyl-actoid purpura, pericarditis, and exacerbation of systemic lupus erythematosus, benign intracranial hypertension in adults disappearing on discontinuation of the medicine, haematologic abnormalities such as haemolytic anaemia, thrombocytopenia, neutropenia, and eosinophilia. LD50=262 mg/kg(i.p. in rat)

Doxycycline Hyclate Patient Information

Doxycycline Hyclate Organisms Affected

Enteric bacteria and other eubacteria